MARCHF1 and HIV-1 infection: Thus, the evolution of a specific HIV-1 countermeasure for MARCH1 through Vpu-dependent modulation of miRNA-25 and miRNA-93 highlights the likely importance of MARCH1 antiviral activity during HIV-1 infection of macrophages.